BJDX
Bluejay Diagnostics Inc
NASDAQ: BJDX · HEALTHCARE · MEDICAL DEVICES
$1.88
+4.44% today
Updated 2026-04-30
Market cap
$1.96M
P/E ratio
—
P/S ratio
54.99x
EPS (TTM)
$-15.25
Dividend yield
—
52W range
$2 – $17
Volume
0.2M
Bluejay Diagnostics Inc (BJDX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $75.00 | $249040.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | +331953.3% | -100.0% | — | — |
| Cost of revenue | $142975.00 | $157039.00 | $145719.00 | $200129.00 | $780955.00 | $199097.00 | $170681.00 |
| Gross profit | $-142975.00 | $-157039.00 | $-145719.00 | $48911.00 | $-780955.00 | $-199097.00 | $-170681.00 |
| Gross margin | — | — | -194292.0% | 19.6% | — | — | — |
| R&D | $454610.00 | $527253.00 | $1.15M | $4.15M | $5.71M | $3.47M | $3.05M |
| SG&A | $884000.00 | $596116.00 | $1.79M | $4.76M | $4.31M | $3.69M | $3.91M |
| Operating income | $-1.63M | $-1.20M | $-3.23M | $-9.32M | $-10.31M | $-7.17M | $-6.95M |
| Operating margin | — | — | -4306884.0% | -3741.5% | — | — | — |
| EBITDA | $-1.49M | $-1.04M | $-2.98M | $-9.01M | $-9.17M | $-6.70M | $-6.68M |
| EBITDA margin | — | — | -3966826.7% | -3618.5% | — | — | — |
| EBIT | $-1.63M | $-1.20M | $-3.12M | $-9.32M | $-9.95M | $-6.89M | $-6.85M |
| Interest expense | $0.00 | $26997.00 | $367459.00 | $20828.00 | $0.00 | $823028.00 | $839.00 |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-757716.00 | $-1.13M | $-3.73M | $-9.30M | $-9.95M | $-7.72M | $-6.85M |
| Net income growth (YoY) | — | -48.6% | -231.3% | -149.3% | -7.1% | +22.5% | +11.3% |
| Profit margin | — | — | -4972914.7% | -3733.1% | — | — | — |